Berger Montague PC Investigates Stryker Corporation's Board of Directors for Breach of Fiduciary Duty (NYSE: SYK)
Stryker (SYK) had its price target lowered by Truist Financial Corporation from $395.00 to $380.00. They now have a "hold" rating on the stock.
Stryker (SYK) had its "buy" rating reaffirmed by BTIG Research. They now have a $397.00 price target on the stock.
Stryker (SYK) is now covered by Leerink Partners. They set an "outperform" rating and a $410.00 price target on the stock.
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio